Ebola Virus Transmission Initiated by Systemic Ebola Virus Disease Relapse
During the 2018-2020 Nord Kivu Ebola virus disease (EVD) outbreak in the Democratic Republic of the Congo, an individual who had received the Merck rVSV-ZEBOV vaccine was diagnosed with EVD. His treatment included an Ebola virus-specific monoclonal antibody (mAb114), and he recovered within 14 days...
Gespeichert in:
Veröffentlicht in: | The New England journal of medicine 2021-04, Vol.384 (13), p.1240-1247 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | During the 2018-2020 Nord Kivu Ebola virus disease (EVD) outbreak in the
Democratic Republic of the Congo, an individual who had received the Merck
rVSV-ZEBOV vaccine was diagnosed with EVD. His treatment included an Ebola
virus-specific monoclonal antibody (mAb114), and he recovered within 14 days but
re-presented six months later with severe EVD-like illness and Ebola virus
viremia and died. We initiated an epidemiological and genomic investigation that
showed the patient had a relapse of acute EVD, which led to a transmission chain
that resulted in 91 cases spanning six health zones over four-months. |
---|---|
ISSN: | 0028-4793 1533-4406 |
DOI: | 10.1056/NEJMoa2024670 |